Company intelligence / Profile preview

Esplanade Ventures

Toronto, Ontario, Canada

Ownership: Private
Development stage: Other

Overview

Esplanade Ventures is a venture capital firm focused on investing in early-stage digital health and medtech companies (with a significant digital component). They target Class I and Class II (510k) medical devices, including digital therapeutics and AI software, with investments ranging from $0.5M–2.5M, primarily in Seed to Series B stages. The firm is phase agnostic and operates out of offices in Montreal and Toronto.

Industry: Investors

Beyond the preview

Go deeper on Esplanade Ventures.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Esplanade Ventures.

Explore the full profile